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 Rates of antibiotic resistance in bacteria are rapidly rising; this is, in part, due to overuse 
of antibiotics resulting in a great burden on the U.S. healthcare system. With the rise of resistant 
bacteria, a large-scale outbreak of antibiotic resistant bacterial infections may also occur. 
Research on developing antibiotics has also decreased. Thus healthcare is at a great disadvantage 
in the arms race against bacteria. The environmental reservoirs of antibiotic resistance are 
currently being explored in Kentucky, in which bacteria have been collected from a broad 
spectrum of natural environments to analyze their antibiotic resistant capabilities and their 
interactions with other environmental organisms. Twenty-seven different genera are represented 
among 138 antibiotic resistant bacterial isolates collected and ten of the genera are known human 
pathogens. Experiments on representative isolates were conducted to examine the (i) antibiotic 
resistance profiles, (ii) ability to consume antibiotics as sole carbon sources, (iii) interaction with 
two plant models, and (iv) interaction with two fungal species. Results obtained from these 
experiments showed that a representative bacterial panel of strains had high sensitivities to two 
of the nine antibiotics tested (rifampicin and tetracycline), and low resistance to one of the 
antibiotics tested (colistin).  However, most of the isolates in our panel were unable to consume 
antibiotics as a carbon source suggesting that they tolerated the antibiotics rather than 
metabolized them.  Additionally, the interaction between our strain panel and its putative 
ecological partners showed low levels of pathogenicity in plant models but a differential 
competitive ability against two fungal strains.  These results indicate that our small bacterial 
representative panel can be used for future studies as they may represent larger populations of 
native bacteria found in Kentucky. 
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Introduction 
 Antibiotic resistant bacteria are quickly emerging worldwide due to overuse or misuse of 
antibiotics. The Centers for Disease Control and Prevention (CDC) has classified a number of 
bacteria that are becoming resistant to many available antibiotics and potential threats to the U.S. 
healthcare system, patients, and their families [40]. The quick increase in resistant bacteria is due 
to the rapid spread of resistance between bacteria over time. 
 
Mechanisms for Antibiotic Resistance Spread 
 The emergence of antibiotic resistant bacteria is often due to bacteria obtaining plasmids 
(or other mobile DNA elements) containing genes whose protein products confer antibiotic 
resistance. A plasmid is a small, circular, double stranded DNA molecule that is separate from 
the larger chromosomal DNA within a bacterium. Due to the distinct separation of the 
chromosomal DNA and plasmid, plasmids are considered to be non-essential for basic cell 
function but instead offer advantages to survival. For example, plasmids bearing antibiotic 
resistance cassettes, which are mobile genetic elements that contain genes and recombination 
sites allowing for genes to be removed or inserted into the cassette and the plasmid itself, may 
confer resistance to a bacterium in the presence of a specific selective agent. Not only do 
plasmids sometimes contain antibiotic resistance genes, but they may also contain genes that 
encode a structure known as a conjugative pilus, which would allow a bacterium to transfer 
plasmids with another bacterium through a process known as conjugation. Conjugation allows a 
donor bacterium to distribute plasmids (potentially containing antibiotic resistance cassettes) to 
neighboring bacteria, therefore making them newly resistant to certain antibiotics [4].  
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 Conjugation and other methods for DNA transfer between bacteria [i.e. transformation 
(uptake of free DNA) or transduction (DNA transferred from bacteriophages)] could result in the 
emergence of opportunistic, antibiotic resistant bacterial pathogens that could now cause 
morbidities in humans where initially the bacterial strains were harmless. Not only can it create 
resistant bacteria but also multi-drug resistant bacteria otherwise known as “super bugs” such as 
methicillin resistant Staphylococcus aureus (MRSA) or extremely drug resistant (XDR) 
Klebsiella pneumoniae [3]. Some strains have even been reported to be pan resistant – resistant 
to all antibiotics tested [24].  Since many of the opportunistic, antibiotic resistant bacteria 
causing human infections are genetically distinct rather than clonal, as one would expect from an 
outbreak spread patient-to-patient, it is highly likely that many of the resistant bacteria are 
acquired from environmental sources [25]. 
  Pathogenic Gram-negative bacteria are deemed difficult to eradicate due to the unique 
composition of their cell wall, having an outer and inner membrane, and porins on the outer 
membrane [36]. The outer membrane allows resistance to many antibiotics that are effective 
against Gram-positive bacteria. Many Gram-negative bacterial strains are becoming increasingly 
resistant to many or most available antibiotics; thus placing a great burden on the U.S. healthcare 
system [40]. Research leading to the development of new antibiotics has also been reduced [10; 
29; 33] because of the large cost of research, development, and clinical trials. 
 
Cystic Fibrosis and Antibiotic Resistant Pathogens 
 Cystic Fibrosis (CF) is a genetic disorder that results in persistent lung infections and 
leads to gradually decreased capability to breathe in the patient. It is caused by a defect in the 
human CFTR gene, which encodes a chloride ion transporter.  The result of any one of a number 
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of potential mutations in this gene is the build-up of viscous mucus on the linings of the lungs 
and gastrointestinal tract.  This sticky mucus is very carbon rich and thus a good food source for 
bacteria.  Patients with CF experience bouts of bacterial pneumonia over the course of their life 
leading to lung scarring and pulmonary decline.  Many people with CF are treated 
prophylactically and during exacerbation events with high doses of antibiotics [32].  Two 
particular antibiotics that have been commonly used to treat Gram-negative bacterial infections, 
specifically in CF patients, are tobramycin and colistin [5; 11; 13; 20; 22; 28; 32; 34]. 
Tobramycin, an aminoglycoside antibiotic that disrupts protein synthesis in bacteria, has been 
effective at treating Gram-negative bacterial infections [7] and is commonly used to treat CF 
patients prophylactically through nebulization.  Additionally colistin, a polymixin antibiotic that 
interferes with cell wall synthesis in bacteria, has been reassessed as being an option for treating 
multi-drug resistant bacterial infections [21] and is a common antibiotic given to CF patients 
during periods of lung decline due to pneumonia. However, some CF pathogens have the ability 
to resist tobramycin and/or colistin treatment [5; 23]. 
 Resistance to tobramycin can be mediated by two main mechanisms.  First, bacteria can 
alter the permeability of their cell membrane thus leading to a decrease in the uptake of the 
antibiotic [23; 29]. Mechanisms for impermeability are still undetermined though two proposed 
mechanisms are alterations in the lipopolysaccharide or changes in outer membrane proteins 
[23]. Second, tobramycin resistance can evolve through enzymatic modifications of the antibiotic 
using N-acetyltransferases (which catalyze acetyl CoA-dependent acetylations of the antibiotic) 
and O-adenyltransferases (which catalyze ATP-dependent adenylation of tobramycin) – both of 
which cause a structural modification that prevents the antibiotic from binding to the ribosome 
[29]. Alteration of the permeability in the membrane is the predominant resistant mechanism 
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against tobramycin with a small percentage of the resistant bacterial population having enzyme 
modification as the resistant mechanism. An even smaller population utilizes both mechanisms 
for resistance [23]. 
 Resistance to colistin can emerge in several different ways, two of which are similar to 
tobramycin resistance.  One method in resistance is the bacterium’s ability to reduce the uptake 
of the antibiotic by releasing the antibiotic back into the environment quickly with the aid of 
efflux pumps. Colistin resistance can also be mediated through enzymatic modification of the 
antibiotic which reduces/prevents it from binding to the target, cellular phospholipids [21]. One 
unique resistance to colistin not seen in tobramycin resistance is the mutation the ipxA. This gene 
is essential for biosynthesis of lipid A, which is the precursor for the biosynthesis of 
lipopolysaccharide that serves as a major component of the outer cell membrane of the Gram-
negative bacterium. The mutation leads to absence of production of lipid A and renders colistin 
ineffective since colistin acts by binding to lipid A in order to function [26]. Though this 
mutation has only been reported in a few bacteria such as Acinetobacter baumannii [26]. 
 
Methods to Studying Antibiotic Resistance 
 One common method in assessing a bacterium’s susceptibility to an antibiotic is the 
minimum inhibitory concentration (MIC) assay. An MIC assay is performed by subjecting a 
bacterial population to decreasing concentrations of an antibiotic. This is normally done in 96-
well plates that are incubated for 24-48 hours. After the incubation period, the lowest 
concentration of antibiotic that causes no visible growth of the bacterium in a well is the MIC of 
the bacterium [15]. MIC is a technique that provides insights into the extent of resistance towards 
an antibiotic of a bacterial isolate though it is limited because it is based on observable growth.  
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For most bacteria, concentrations of up to 100,000 bacterial cells per milliliter are not observable 
with the naked eye; thus, there may be limited but unobservable growth in a well in response to 
an antibiotic.   
 Despite this limitation, the results obtained from an MIC assay can be further interpreted 
as to how sensitive or susceptible the bacterium is against a particular antibiotic. Once a 
bacterium has been confirmed as resistant towards a particular antibiotic, the bacterium can be 
further studied in search of the molecular mechanism that conveys resistance. A common and 
useful method in closely studying mechanistic steps in resistance would be the use of polymerase 
chain reaction to identify known antibiotic resistant cassette markers.  One limitation of this 
method, however, is that it will not identify unknown or novel mechanisms.  
 
Other Means to Studying Antibiotic Resistant Environmental Isolates 
 What are the ecological roles of these antibiotic resistant bacteria? There are numerous 
ways to answer this question.  This study will focus on the interaction of these isolates with fungi 
and plants that may occupy the same environmental niche as the bacteria.  
 Bacteria interact with plants in a variety of ways.  Plants and bacteria can form beneficial 
symbioses such as those rhizobial bacteria that can produce nitrogen-fixing root nodules on the 
root hairs of leguminous plants.  Conversely, the relationship can be adversarial as in the case of 
plant pathogens.  In this case, the bacterium must penetrate the thick plant cell walls in order to 
cause destruction of tissue and dissemination though the plant.  Researchers commonly study 
plant models such as Arabidopsis or cultivated vegetables to study plant pathogenesis [37].  The 
latter plant models include using onions or lettuce leaves to simulate live plants in a research 
laboratory. 
 10 
Mechanistic studies have shown that some pathogenic bacteria produce similar subsets of 
virulence determinants that cause disease in animals and plants [30]. In many cases, plants have 
evolved defense mechanisms such as the use of phytochemicals to combat pathogenic bacteria 
that are different from animal defenses. From this, another beneficial use of plant models would 
be the discovery of a possible source of new therapeutics (i.e. phytochemicals) [30]. 
 Another method to analyze these bacterial isolates would be to study microbial 
interactions because many of the antimicrobials commonly used in clinics are actually natural 
products derived from environmental organisms thought by some to be involved in interspecies 
communication.  For example, the genus Streptomyces accounts for 80% of all antibiotics 
approved for human use and includes streptomycin, cephalosporins, chloramphenicol, neomycin, 
tetracycline, nystatin, cycloserine, vancomycin, kanamycin, fosfomycin, and the newer 
antibiotics daptomycin and platensimycin [31]. Additionally, fungal species can produce 
antibiotic (e.g. penicillin – described more below).  Microbial interaction between microbes can 
be mutualistic, commensal, competitive, or inhibitory depending on the microbes involved. 
 In addition to antibiotics produced by fungi, some of the antibiotics that have been used 
clinically since the 1920’s were developed from fungi. Penicillin was discovered and developed 
from a study of bacterial interactions with the Penicillium genera of fungi [16]. Penicillium 
species evolved mechanisms to promote survivability, increase competitiveness, or to act as a 
defense mechanism against other microbes [28]. One mechanism was the secretion of 
antibacterial compounds, which later evolved into penicillin. There are many fungi that reside in 
natural environments alongside with bacteria and many of the microbial interactions are 
competitive or inhibitory.  One pathogenic fungus used in this study, Aspergillus fumigatus, has 
been shown to produce potent antibacterial compounds [12; 38; 41] and is readily found in the 
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soil or decaying organic matter.  On the other hand, the human commensal fungus Candida 
albicans has been shown to work in concert with the human microflora to build biofilms, 
particularly in the oral cavity [6] but has also been isolated from soils, waters, and in association 
with plants [27]. This suggests that fungi and microbes can maintain mutualistic relationships as 
well as competitive/inhibitory relationships; however whether they are actively growing in such 
environments or are just deposited from animal feces is still unclear.   
 Another method to analyze these bacterial isolates would be to study the mechanism that 
conveys resistance. Resistance mechanisms are normally on the molecular level involving 
changes to certain structures or involving enzymes. Recently, there has been an increase interest 
in bacteria that are able to not only tolerate the antibiotic but also metabolically consume it. It 
has been observed that certain clades of bacteria can utilize antibiotics as carbon sources; that is, 
these bacteria have the ability to consume the antibiotics as food [9]. Growth of a bacterium on 
the medium containing the antibiotic as a sole carbon source indicates that the bacterium is 
resistant to the antibiotic and may be either able to breakdown the antibiotic for metabolic 
consumption or fix CO2 as an autotroph. Fully understanding how the bacterium renders an 
antibiotic useless or less effective allows researchers to pinpoint and target essential molecular 
steps in hopes of eradicating or controlling the bacterium. 
 With the rise of antibiotic resistant bacteria, the push for antibiotic research or treatment 
against such bacteria must be maintained to prevent continuing instances of pan-resistant 
organisms and outbreaks. The goals of this study are to investigate the antibiotic resistant 
capabilities of the bacterial isolates collected in Kentucky and examine the ecological roles of 
these organisms in their environment. The main hypotheses of this project are that the bacterial 
isolates obtained in natural environments within Kentucky are resistant to many antibiotics and 
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that bacterial isolates found in soil environments will be able to consume antibiotics. We further 
hypothesize that some bacterial isolates will be plant pathogens and some bacterial isolates will 
be inhibited by antibacterial compounds produced by the fungi. 
Materials and Methods 
Sampling Antibiotic Resistant Bacterial Isolates 
Making LB Agar Plates Containing Antibiotics 
 In order to study the bacteria of interest, Lennox LB (Luria-Bertani) agar plates were 
prepared. Plain Lennox LB agar is a nutrient medium essential for microbial growth and was 
made by dissolving 35 g of Lennox LB agar powder (IBI Scientific) into 1 liter of ultrapure 
water. Lennox LB agar contains 15 g of agar, 10 g of tryptone, 5 g of yeast extract, and 5 g of 
sodium chloride per liter. The medium was then autoclaved and placed in a 55°C water bath until 
cooled. To select for only antibiotic resistant bacteria, tobramycin and colistin were added into 
the medium (to final concentrations of 25 mM and 9 mM for colistin and tobramycin 
respectively) with swirling to help distribute them evenly. The medium was then poured out into 
plates and the plates were flipped after solidifying for overnight drying. Flipping the plates 
prevents possible contamination from water droplets that condenses onto the lid due to the heat 
from the medium. 
 
Sampling and Collecting Bacterial Isolates 
A group of undergraduate and post-bac students and I surveyed natural environments 
within Kentucky that had a low human activity. The group was divided into four teams, each 
with a specific natural environment to survey for bacteria (i.e. association with animals or fungi, 
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plants, water, and soils). The teams spread out and traveled to different areas within Kentucky 
stretching east from Louisville to Ashland and south to Elizabethtown (Supplemental Figure 1). 
Being part of the team to survey plants, our methods in sampling and collecting bacterial isolates 
were slightly different than the other three teams. Plants were surveyed in multiple different 
areas in Louisville parks (Supplemental Figure 2). Boston lettuce, broccoli, and an ear of a corn 
were obtained from groceries procured at a Kroger grocery store (4303 Winston Ave, 
Convington, KY 41015). The plants chosen were sampled by swabbing the external surfaces 
with a sterile cotton swab damped with sterile ultrapure water. The swab was then used to 
inoculate an LB plate supplemented with colistin and tobramycin antibiotics and incubated at 
37°C in order to grow cultures of the bacteria for further study within the lab. 
 
Determining Resistance to Additional Antibiotics by Plating 
 The bacterial isolates that grew on colistin- and tobramycin-containing LB agar plates 
were transferred to LB agar plates containing up to three additional antibiotics (i.e. carbenicillin, 
erthryomycin, and irgasan). Plates were made similarly to as described above but with different 
combination of antibiotics. Plates contained a combination of carbenicillin (500 μg/mL) and 
irgasan (25 μg/mL); erthryomycin (500 μg/mL) and irgasan (25 μg/mL); or all five antibiotic 
used thus far. Resistance to these antibiotics was determined by examining the streaked area for 
visible growth of bacteria.  Individual colonies (in contrast to full streaks) were not used as an 
indication of antibiotic resistance because, individual colonies are more likely the result of 
mutations in the face of selection than full streaks, which indicates that antibiotic resistance is 
common among the colonies. 
 
 14 
Identification of Resistant Bacterial Isolates 
 
Extraction of Genomic DNA from Bacterial Isolates 
 Half of the identification was done by a group of undergraduate and graduate students in 
a summer research lab experience (including myself). The remaining half was done by a post-bac 
student, Eric Curtsinger, and myself.  Genomic DNA (gDNA) was extracted from each bacterial 
isolate using a DNeasy Blood and Tissue kit (Qiagen). The concentration of each gDNA sample 
was determined using a Nanodrop 2000 spectrophotometer (Thermo Scientific) at 260 nm. 
Concentrations were adjusted to 50-600 ng/mL to ensure that there was enough gDNA for 
sequence amplification. 
 
Polymerase Chain Reaction of the Small Ribosomal rRNA Gene 
 
The 16S ribosomal rRNA gene was the target for amplification with each isolate gDNA 
sample. This gene is commonly used to identify bacterial strains [17]. Two different high-fidelity 
polymerases were used to amplify the 16S gene region for each bacterial isolate gDNA sample to 
increase the accuracy of sequencing. However each halves of the bacterial isolates had a 
different polymerase. For each gDNA, a master mix was made using the HotStar polymerase 
(Qiagen).  Each reaction (or isolate reaction) contained 10 μL of Q-solution, 10 μL of 5x 
solution, 2 μL of upstream 16S universal primer 27F (5'- AGAGTTTGATCMTGGCTCAG -3ʹ; 
[17]; 10 pmol/L), 2 μL of 16S universal downstream primer 1392R (5ʹ- 
ACGGGCGGTGTGTRC -3ʹ; [17]; 10 pmol/μL), 1 μL of HotStar polymerase (2.5 units/μL), 25 
μL of sterile ultrapure water, and 1 μL of the template (bacterial gDNA). A second master mix 
consisted of 10 μL of 5X KAPA solution (KAPA Biosystems), 2 μL of upstream primer 27F, 2 
μL of downstream primer 1392R, 1 μL of KAPA polymerase (1 unit/µL), 1.5 μL of dNTP mix 
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(10 mM each) , 33.5 μL of sterile ultrapure water, and 1 μL of template. The reactions were then 
subjected to PCR using different programs for the two polymerases based on manufacturer’s 
recommendations. The program for the PCR reactions with HotStar was: 5 min at 95°C; 35 
cycles of 1 min at 94°C, 1 min at 55°C, 2 min at 72°C; 10 min at 72°C; and holding at 4°C. The 
program for reactions using KAPA was: 5 min at 95°C;  30 cycles of 1 min at 98°C, 1 min at 
60°C, 2 min at 72°C; 10 min at 72°C; and holding at 4°C. After the PCR programs were 
completed, the products were electrophoresed on a 1% agarose gel, and each sample was 
examined for the presence of a ~1400 bp band corresponding to the 16S rRNA gene. Samples 
containing only one strong band of the proper size were purified using the QIAQuick PCR 
purification kit (Qiagen) in order to remove any traces of remaining primers, enzymes, and salts 
prior to sequencing. 
 
Sequencing and Identification 
 The purified PCR products were sequenced at Macrogen (Baltimore, MD) using the 
Sanger method to determine the 16S DNA sequences. These DNA sequences were compared to 
DNA sequences in two databases, GenBank (a national gene and protein database) using the 
BLAST (Basic Logic Alignment Search Tool) algorithm [1] and the RDP (Ribosomal Database 
Project, only contains 16S gene sequences) [8; 42]. By comparing experimentally determined 
16S rDNA sequences from the isolates with sequences from databases, the most closely related 
genus/species for all isolates was established.  In all cases, the most closely related species 
showed at least a 98% identity to the query sequence suggesting a close match. 
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Selection and Preparation of Bacterial Isolates 
Of the 138 bacterial isolates, 36 isolates were chosen to represent the 27 genera to be 
tested in the MIC assays, lettuce infection assays, fungal-bacterial interaction assays, and 
antibiotic single carbon source assays. The isolates were selected by choosing 1-3 representative 
isolates from each of the 27 genera. Genera containing more than five isolates had at least 2-3 
representative isolates selected. The classification of the 36 isolates has been abbreviated for 
simplicity (Supplemental Table 1). Bacterial isolates were prepared by obtaining the isolates 
from frozen 20% glycerol stocks and streaking them on LB agar plates. The plates were then 
incubated at 37°C for 24-48 hours. After incubation plates wrapped with parafilm and stored at 
room temperature for subsequent experiments. 
 
Minimum Inhibitory Concentration (MIC) Assay 
 
Preparation of Antibiotic Solutions 
 Antibiotic solutions were prepared for use in 96-well plates for the minimum inhibitory 
concentration assay. Each antibiotic stock solution concentration was 50 mg/mL. Each antibiotic 
was prepared by dissolving 50 mg of the antibiotic into 1 mL of an appropriate solvent (Table 
1). Antibiotics that were dissolved in water were then filtered through a 22 μm syringe filter to 
ensure sterility. Antibiotic solutions were then aliquoted and stored at -20°C. Tubes containing 







Table 1. Antibiotic  Information. 









Inhibits translation by 
blocking peptidyl transferase 
on the 50S 
G+ and G- Ethanol – 50 
Colistin Polypeptides 
Disrupts the outer cell 
membrane 
G- Water – 50 
Kanamycin Aminoglycosides 
Binds to 70S ribosomal 
subunit and inhibits growth of 
the bacterium 





Interferes with RNA and 
protein synthesis 





synthesis in cell walls 
G+ and G- Water – 100 
Rifampin Others 
Inhibits RNA polymerase 




Inhibits protein synthesis and 
ribosomal binding of 
aminoacyl-tRNA 
G+ and G- Water – 50 
Tobramycin Aminoglycosides 
Inhibits formation of the 70S 
ribosomal complex 
G-, some G+ Water – 50 
Trimethoprim Sulfonamides 
Interferes with DNA 
synthesis 
G+ and G- DMSO - 50 
 
Normalizing Bacterial Isolates 
 Since the bacterial isolates used in this study are different in terms of growth rates or cell 
size, normalizing the bacterial isolates based on culture density allows the MIC data to be 
compared to one another.  Each bacterial isolate was inoculated into a test tube containing 5 mL 
LB liquid and incubated at 35-37°C on a roller drum for approximately 24 hours. The roller 
drum allows adequate circulation of nutrient and oxygen within the test tube enabling the 
bacteria to grow at an optimal rate. After 24 hours, optical densities at 600 nm (O.D.600) of the 
liquid cultures were obtained using a BioPhotometer (Eppendorf). Each liquid culture was 
diluted by a factor of 10 before measuring the O.D.600 (to ensure the reading would be in the 
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linear range of the spectrophotometer) by pipetting 100 μL of each liquid culture and 900 μL of 
plain LB liquid into each cuvette and mixing to establish a uniform suspension of the bacteria. 
The spectrophotometer was blanked with plain LB liquid prior to each O.D.600 reading. The 
desired O.D.600 to normalize all isolates was 1.0 ± 0.1 and each isolate was diluted with LB 
liquid if over that range.  No isolates had overnight O.D.600 readings of less than 1.0. 
 
Preparing 96-well Plates for MICs 
 Approximately 90 96-well, non-tissue culture treated plates (10 plates for each antibiotic) 
were prepared in the presence of a nearby lit Bunsen burner. The Bunsen burner was used as a 
heat barrier to prevent any falling debris or bacteria in the air from contaminating the plates 
during the preparation. Each plate were prepared by pipetting 200 μL of plain LB liquid into 
each well then an additional 195.9 μL into the first row, Row A. Then 4.1 μL of a specific 
antibiotic was pipetted into each well in Row A to achieve a final concentration of 512 μg/mL. 
The concentration of the antibiotic was then serially diluted by transferring 200 μL from Row A 
to Row B with mixing, then 200 μL of Row B was transferred to Row C with mixing. This was 
repeated until Row E where 66 μL of Row E was transferred to Row F with mixing then 66 μL 
of Row F was transferred to Row G with mixing. Row H did not contain antibiotics to serve as 
positive controls for bacterial growth. The final antibiotic concentrations for each row on the 96 
well plates were as follows: Row A (512 μg/mL), Row B (256 μg/mL), Row C (128 μg/mL), 





 To inoculate each plate, 5 μL of each normalized bacterial liquid culture was pipetted in 
triplicate for each antibiotic to account for biological variability. A Bunsen burner was still used 
to establish a barrier during inoculation. Positive controls were included on all plates (isolates 
inoculated into LB with no antibiotics in Row H of each plate). Negative controls were also 
included on all plates  which was a column consisting only plain LB liquid though, in some cases 
when the antibiotic stock solution was either cloudy or colored, contained the antibiotic also (e.g.  
rifampin). After inoculation, the plates were wrapped twice with parafilm to prevent evaporation 
during incubation. Parafilm seals the plates and can sometimes tear upon even mild heating, 
resulting in small gaps or openings to the plate; therefore each plate was wrapped twice to 
prevent any small openings that could cause evaporation. To ensure that the bacterial isolates 
were not limited for oxygen, two plates were incubated together (one wrapped with parafilm and 
one not wrapped with parafilm). Both plates had the same bacterial isolates and antibiotics used. 
The O.D.600 readings for both plates were similar. The volume of solution for the plate with no 
parafilm did decrease slightly in some wells. Thus the parafilm prevented the loss of solution 
volume and did not limit oxygen access to the bacterial isolates. A decrease in any well volume 
would affect the O.D.600 reading during the analysis step by increasing the actual O.D.600 reading 
due to concentrating the bacterial isolates. Finally, the 96-well plates were incubated for 
approximately 24-48 hours at 37°C without shaking. 
 
Reading the Plates 
 After the incubation period, the plates were removed from the incubator and stripped of 
the parafilm. The plates were then read using a Sunrise plate reader (Tecan), which measured the 
O.D.600 of the culture in each well. Each well was scanned 3 times by the machine and the 
average of each set of readings was given as the output. 
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MIC Determination and Statistical Analysis 
 To determine the MIC of each antibiotic on each strain, 96-well plates were examined for 
observable growth.  Wells lacking observable growth showed O.D.600 readings between 0 and 
0.16 (due to the variation in the background and media and because the spectrophotometer did 
not allow for blanking the readings) while those showing observable growth had readings above 
this level.  Therefore, we chose 0.16 as the baseline to determine the minimum inhibitory 
concentration for each replicate in each antibiotic.  For each sample, the data were examined for 
the antibiotic concentration at which the O.D.600 fell below or equally to 0.16 and this was taken 
as the MIC for that sample. Each antibiotic MIC was then plotted using GraphPad Prism 5 
(graphing software). 
   
Onion Infection Model Assay 
 Half of the isolates collected by the group of students were also tested in the onion 
infection assay. The remaining half of the isolates was done with the aid of another post-bac 
student, Devin McBride, and myself. In preparation, each bacterial isolate was inoculated into a 
5 mL plain LB liquid test tube and incubated at 35-37°C on a roller drum for approximately 24 
hours. 
 
Preparing the Onion Material 
 Bags of yellow onions were bought from a Kroger grocery store (200 New Albany Plaza, 
New Albany, IN 47150 and 3165 S 2nd St, Louisville, KY 40208) for this assay. The skin of the 
onion was removed including the outer layer. The gloves being worn, the onions, and the bench 
top were sprayed with 70% ethanol for sterilization. This method was described in Jacobs et al. 
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[18]. The onions were cut in quarters with a kitchen knife, which had been disinfected with 70% 
ethanol. The layers were then peeled off of one another and cut into approximately 1 inch 
sections. Only healthy onion peels, indicated by no markings on the peels, were used. The onion 
peels were placed in an acrylic bin lined with absorbent cloth dampened with sterile water to 
prevent desiccation of the onion peels. The center of each onion peel was gently pierced with a 
P200 micropipette tip to serve as the inoculation site. 
 
Inoculation and Infection Assay 
Each onion peel was inoculated with 5 μL of a designated bacterial liquid culture. Each 
bacterial isolate were inoculated into three adjacent onion peels to produce triplicates. The 
acrylic bin was covered with Saran wrap or aluminum foil and incubated at 37°C for 
approximately 48 hours as described in Jacobs et al [18]. The positive control was Burkholderia 
cepacia strain ATCC 25416 (a known onion pathogen) [18], and the negative controls were 
Pseudomonas sp. or no bacterial inoculation. The onion peels were photographed every 24 hours. 
The data obtained were analyzed by comparing pictures of the onion peels before incubation and 
at the end of the incubation period (Supplementary Figure 3) and rated on a scale of 0 (no 
maceration) to 3 (massive tissue destruction) based on published protocols [18]. 
 
Lettuce Infection Model Assay 
 
Preparing the Lettuce Material 
 Bags of romaine lettuce were bought from a Kroger grocery store (3165 S 2nd St, 
Louisville, KY 40208). All leaves were detached from healthy-looking cores and discarded since 
the core served as the infection site. The lettuce cores were then washed with 0.1% bleach and 
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rinsed with deionized water twice. The cores were then placed in a bin that has been lined with 
absorbent cloth soaked in 10 mM magnesium sulfate as described in the Starkey and Laurence 
protocol [37]. The magnesium sulfate was used to provide humidity within the bin and prevent 
the lettuce cores from desiccating. 
 
Inoculation and Infection Assay 
 Triplicates were made for each bacterial isolate. Each core was inoculated in the center 
with a designated isolate, from the isolate’s LB agar plate, using a toothpick. The positive control 
was inoculation with Pseudomonas aeruginosa, a known lettuce pathogen [37], and the negative 
control was not inoculated with a bacterial isolate. The bin was then covered with Saran Wrap to 
further slow the lettuce cores from drying out. The bin was then incubated at 30°C for five days. 
Throughout the course of the incubation period, the absorbent cloth was kept damp with 
magnesium sulfate and the lettuce cores were photographed each day and six hours later each 
day for five days. The data obtained were analyzed by comparing pictures of the lettuce core 
before incubation and at the end of the incubation period (Supplementary Figure 4). Rating 
based on maceration level was done by assigning the negative control a score of 0, the positive 
control a score of 3, and any intermediate maceration in-between the two mentioned scores was 
determined subjectively. 
 
Fungal and Bacterial Interaction Assay 
Making Yeast Peptone Dextrose (YPD) Agar Plates 
 YPD plates were used in this experiment to allow the growth of fungi on agar plates. 
YPD plates were made by dissolving 10 g yeast extract, 20 g bacterial peptone, 20 g glucose or 
dextrose, and 15 g bacto agar into 1 L of ultrapure water. The medium was then mixed 
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thoroughly, autoclaved, and placed in a 55°C water bath to cool. Then the medium was poured 
into petri dishes where it was left to cool on the bench top. Finally after the medium had 
solidified, the plates were flipped and left for overnight drying. 
 
Inoculation of Fungi and Bacterial Isolates 
 The fungi used in this study were Aspergillus fumigatus (ATCC B5852) and Candida 
albicans (ATCC 23R). The inoculation process involved making three long streaks, which were 
evenly spaced, of one of the fungi on a standard 100 millimeter YPD agar plate. Then three short 
streaks of a designated bacterial isolate were made to be perpendicular to the three long fungus 
streaks using sterile applicators between streaks; therefore it would appear that there were three 
intersections of the streaks made representing triplicates of the bacteria isolate (for example, see 
Supplementary Figure 5). This method was done for all isolates and the overall procedure was 
repeated for the other fungus. The plates were then incubated for approximately 24 hours at 
37C.  The procedure was then performed again but this time the three long streaks were 
streaked from a bacterial isolate and the three short perpendicular streaks were streaked from a 
fungus. This was done for all bacterial isolates. The two fungi were also plated individually to 
serve as positive controls. Positive controls for all of the isolates were also streaked on separate 
plates. 
 
Analyzing the Interactions 
 After the incubation period, the plates were examined to see the interaction between the 
fungi and the bacteria. Controls were used to compare the interaction to see which microbe (i.e. 
fungus or bacterium) outcompeted or inhibited the other since some bacteria looked similar to 
one of the fungi. The interactions between microbes were determined by closely examining the 
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intersection between the streaks of two different microbes. Normally when microbes grow after 
being streaked on a petri dish, they grow in a solid line filling the indention of the streak. Upon 
examining the intersection, if the fungal streak was not disrupted by the bacterial streak, then the 
fungus outcompeted or inhibited the bacteria. If the bacterial streak was not disrupted by the 
fungal streak, then the bacterium outcompeted or inhibited the fungus. 
 
Antibiotic Single Carbon Source Assay 
Making Antibiotic Single Carbon Source (Ab SCS) Plates 
  Ab SCS plates were made by dissolving 40 mM ammonium sulfate, 20 mM 
monopotassium phosphate, 2 mM magnesium sulfate heptahydrate, 0.040 mM sodium EDTA, 
0.016 mM zinc sulfate heptahydrate, 0.031 mM calcium chloride dihydrate, 0.01 mM iron sulfate 
heptahydrate, 0.005 mM manganese chloride tetrahydrate, 0.02 mM boric acid, 0.002 mM 
sodium molybdate dihydrate, 0.001 mM copper sulfate pentahydrate, 0.001 mM cobalt chloride 
hexahydrate, and 0.0006 mM potassium iodide into 1L of ultrapure water [9]. Some chemical 
ingredients were unable to be accurately measured out on the scale due to the scale’s ability to 
measure only to 1 mg; therefore any ingredient under 1 mg were measured out by dissolving a 
single crystal of the certain compound or just enough that was below 1 mg. The pH of the 
solution was adjusted to approximately 5.5 using hydrochloric acid then the mixture was 
sterilized through a 0.22 μm filter into two 500 mL glass bottles. Then 7.5 g of plain Lennox LB 
agar powder was dissolved into each bottle, the medium was autoclaved, and it was placed in a 
55°C water bath to cool. Once cooled, 0.5 g of a specific antibiotic was dissolved into one 500 
mL bottle. The medium was poured out into plates and cooled on the lab bench top until the agar 
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had solidified. The plates were then flipped for overnight drying. It should be noted that only 0.1 
g of colistin was added due to availability and cost of colistin. 
 
Streaking the Ab SCS Plates 
 Plates were divided into eight regions.  Eight isolates were plated in replicate onto three 
individual plates (for triplicates) and the process was repeated until all 35 isolates were streaked 
onto three plates each. Escherichia coli K12 was also plated on each of the nine Ab SCS plate as 
a negative control to ensure the media were made correctly (E. coli K12 is susceptible to many 
antibiotics). The plates were then incubated under 37°C for approximately 24 hours. 
 
Results 
Discovery of Antibiotic Resistant Bacterial Isolates 
Approximately 162 bacterial isolates were collected for this project (i.e. 38 from 
animals/fungi, 44 from water, 35 from plants, and 45 from soils) but only approximately 138 of 
the isolates could be re-grown from freezer stocks and appeared to maintain their resistance to 
colistin or tobramycin. The original goal of the project was to identify specific pathogens which 
were resistant to either carbenicillin and irgasan (for Stenotrophomonas maltophilia) or 
erthryomycin and irgasan (for Burkholderia cepacia complex strains), so the ability of these 
isolates to resist these combinations was tested.  Out of these 138 isolates, only 12 were resistant 
to a combination of carbenicillin and irgasan, 24 were resistant to a combination of erythromycin 
and irgasan, and 8 were resistant to all five antibiotics as shown in Figure 1. These results 
showed that majority of the isolates are resistant to colistin and tobramycin with a few isolates 
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resistant to other antibiotic combinations. If tested with single antibiotics (i.e. just carbenicillin or 
just irgasan), the isolates may have shown a greater response in resistance. 
 
Bacterial Species/Genus Identification 
The genus/species for each cultured isolates was determined by amplification of the 16S 
rRNA gene and comparison to online databases. For most of the isolates, the e-value from 
GenBank (a national gene and protein database) was 0 indicating a strong similarity to known 
isolates.  Similarly, the results from the RDP (Ribosomal Database Project, only contains 16S 
gene sequences) show a strong indication of a single genera or species associated with each 
isolate (i.e. most isolates had a 100% confidence level). The genus identification of some isolates 
were slightly unclear due to having a low RDP confidence level (CL) such as Aminobacterium 
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(CL = 33%), Unclassified Microbacteriacea (CL = 46%) and Falsibacillus (CL = 30%). The 138 
isolates represented 27 different genera in which 10 of the genera are known to contain human 
pathogens [14]. The ten genera that contain pathogenic species are Aeromonas, Bacillus, 
Burkholderia, Enterococcus, Morganella, Providencia, Pseudomonas, Rhodococcus, Serratia, 
and Stenotrophomonas.  
The most predominant genus present in all four mentioned types of environments was 
Serratia, a Gram-negative bacterium (Table 2). Also found in high abundance were Bacillus 
species, Spingobacterium species, and Paenibacillus species.  Other genera were found less 
frequently.  This indicates that there are some species which are more prevalent and might be 
considered ecological generalists while others may be more specialists for an environment.  
These conclusions should be tempered because of sampling bias in siles, samples, environments, 
and due to the specific media that was employed and limited sample number. The resultant 
organisms might be of interest as they might be reservoirs of antibiotic resistance.  Further, they 
may represent rare but emerging opportunistic pathogens in veterinary, agricultural, or human 
infections. Thus, further testing was warranted.  
 
Minimum Inhibitory Concentration Assay 
 The goal of the MIC assays was to assess the representative isolates’ resistant profile to 
the nine antibiotics. Antibiotics were chosen for this assay based on mode of action and 
classification to ensure a broad diversity of antibacterial agents (Table 1). The hypothesis was 
that many of the isolates would be resistant to antibiotics other than tobramycin and colistin. To 
establish whether the isolate collection was resistant only to tobramycin and colistin or broadly 
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to many antibiotics, each representative isolate were inoculated into 96 well plates containing 
serially diluted antibiotics. The antibiotics used in this study were chosen for their breadth in  
terms of their mechanism of action and the types of bacteria they are known to inhibit (Table 1).  
For the genera with an abundance of isolates (e.g. Bacillus, Serratia, and Sphingobacterium - 
Table 2), 2-3 representative isolates were used. The results are shown in Table 3.   
Table 2. Summary of Kentucky Isolates and their isolation sites 
Bacterial Genus 
Number of 
Isolates Isolated From Gram Stain 
Aeromonas 6 Waters - 
Arthrobacter 3 Soils + 
Bacillus 23 Waters, Soils, Insects, Fungi + 
Brevibacillus 8 Water, Soil, Insects + 
Burkholderia 4 Soils - 
Cellulosimicrobium 1 Soil + 
Chromobacterium 1 Water - 
Chryseobacterium 10 Water, Plants - 
Cloacibacterium 1 Water - 
Elizabethkingia 1 Soil - 
Empedobacter 1 Water - 
Enterococcus 2 Animal feces + 
Flavobacterium 1 Water - 
Leucobacter 1 Plant + 
Microbacterium 8 Water, Plant, Soils + 
Morganella 2 Water - 
Myroides 1 Insect - 
Paenibacillus 10 Soils, Waters, Plants + 
Providencia 4 Plants - 
Pseudochrobacterum 2 Soils - 
Pseudomonas 2 Plants - 
Rhodococcus 1 Soil + 
Serratia 31 Plants, Soils, Fungi, Water - 
Sphingobacterium 13 Water, Soil, Insects - 
Stenotrophomonas 1 Soil - 
Total 138     
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 A low MIC reveals that a bacterium is highly susceptible to the antibiotic and a high MIC 
could be interpreted as a low sensitivity or complete resistance against the antibiotic. Most 
isolates that were subjected to colistin, penicillin, tobramycin, or trimethoprim were highly 
resistant to these antibiotics with MICs greater than 512 g/mL (indicated with “**” in Table 3), 
which indicates that they are resistant to all concentrations tested. Most of the isolates that were 
subjected with chloramphenicol, kanamycin, and nalidixic acid had many MIC values in the low 
to intermediate range (i.e. values in the range of 2-512 μg/mL). Most isolates that were subjected 
with rifampin and tetracycline had low MIC values (i.e. values in less than 64 μg/mL), which 
indicate little resistance to these antibiotics in these natural isolates.  
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The dynamics of the interaction between each representative bacterial strain and 
antibiotic is illustrated in Figures 2-10. For each antibiotic, seven strains were analyzed together 
in the same plot to avoid confusion and were combined alphabetically.  Each graph within each 
figure tends to show a consistent pattern for most of the isolates for each antibiotic (e.g. most 
isolates in Figure 2 show a negative relationship between growth and increasing antibiotic 
concentration). The antibiotics chloramphenicol, nalidixic acid, and rifampin showed drastic 
decreases in O.D.600 levels for most isolates as antibiotic concentration increased especially at 
low concentrations. The antibiotics colistin, kanamycin, penicillin, tetracycline, and tobramycin 
showed small decreases growth for most isolates but also a small increase in O.D.600 level for a 
few isolates as antibiotic concentration increased. Trimethoprim showed a unique set of MIC 
results in that more isolates than anticipated had an increasing O.D.600 level as antibiotic 
concentration increased (Figure 10). 
 Plant Model Assay 
 Bacteria in the soil can be beneficial to plants by protecting them against pathogens or by 
fixing nitrogen from the air which is necessary for plant growth.  Bacteria can also be plant 
pathogens and can infect the roots, stems, and leaves of plants. The goal of this assay was to 
determine the pathogenicity of the representative isolates towards onions and lettuce. The 
hypothesis of this assay was that some of the isolates were pathogenic to these two plant models. 
To test the pathogenicity of the representative panel isolates for the ability to cause pathogenesis 
in two plant models – onion bulb and lettuce leaves, the isolates were inoculated into sterile 
onion peels and lettuce cores as described in the Materials and Methods section according to 
published protocols [18, 37]. 
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 Tissue damage was assessed qualitatively and by comparing to control inoculations.  In 
the onion maceration model, surprisingly only two strains, Myroides odoratus and 
Sphingobacterium faecium, showed some form of onion tissue maceration (Figure 11). In the 
lettuce maceration model, five genera of the twenty-seven showed some form of lettuce tissue 
maceration though it was not significant (Figure 11). The majority of the genera were unable to 
visibly infect or macerate either plant model revealing that most of these isolates are not 
pathogens of yellow onions and lettuce. The few that were able to macerate the plants were 
isolates collected from sources that did not involve plants with the exception of one, 
Sphingobacterium faecium. From this, plant-associated bacteria appear to be less likely to be 
plant pathogens. With the controls effectively macerating their respective plant model, the data 
could be interpreted that the plant itself may have been able to defend itself against the bacterial 
isolates or that the isolates lacked the appropriate cellulases or other enzymes that could lead to 
tissue destruction. It could also be that some of these isolates could serve a beneficial role to 
onion or lettuce plants; however, testing this was outside the scope and abilities of our research 
lab. 
 
Fungal and Bacterial Interaction Assay 
 
  The goal of the fungal-bacterial interaction assay was to observe the microbial interaction 
between the representative isolates and the two fungi, A. fumigatus and C. albicans. The 
hypothesis of this assay was that the fungi were capable of outcompeting or inhibiting some of 
the isolates. To observe if there is a microbial interaction between the fungi and bacteria, both 
microbes were cross-streaked as described in Materials and Methods section and depicted in 
Supplementary Figure 5. The bacterial isolates showed variable responses to the fungi when  
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 Another possibility is that some of these isolates could serve a beneficial role to onion or lettuce  
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streaked in different orders (i.e. first or second). Approximately half of the isolates were unable 
to outcompete or inhibit the fungus A. fumigatus when the fungus was streaked first. When the 
bacterium was streaked first, only six isolates were unable to outcompete the fungus (Figure 12). 
 To interpret this graph, an example is given:  Falsibacillus was able to outcompete the A. 
fumigatus when the bacterium was streaked first but unable to outcompete the fungus when the 
bacterium was streaked second. Approximately more than half of the isolates were able to 
outcompete the fungus Candida albicans regardless of the order of microbial streaking (Figure 
13).  It appeared that in some microbial interactions, the order of placement determines the 
microbial competitiveness. Of the isolates outcompeted by A. fumigatus, most of the isolates 
were Gram-positive. Of the isolates outcompeted by C. albicans, most of the isolates were 
Gram-negative. This may reveal that some fungi are more target-specific in regards to bacteiral 
inhibition. 
 
Antibiotic Single Carbon Source Assay 
In a study recently published, researchers identified that some soil bacteria could not only 
tolerate high levels of antibiotics but could consume them as a carbon source [9]. They identified 
these organisms by plating them on a solid medium containing salts and an antibiotic.  To 
determine whether the isolates collected in this study could consume antibiotics in a similar 
manner, we struck our isolates on a minimum salts agar containing 0.5 g/L of antibiotic (0.1 g/L 
for colistin). After growth at 37C, most isolates did not show the capability to consume most of 







Colistin was the only antibiotic that could be consumed by most of the isolates (Table 4). 
Kanamycin, penicillin, tobramycin, and trimethoprim were able to be consumed by less than half 
of the isolates. Chloramphenicol, nalidixic acid, rifampin, and tetracycline were unable to be 
consumed by any isolate with an exception of one or two isolates. This suggests that most of the 
isolates that are resistant to the antibiotics tolerate and detoxify these antibiotics but may not 
break them down for consumption as carbon sources. Since the concentration of colistin used 
was lower than the desired concentration (i.e. 0.10 g/L instead of 0.50 g/L), this may explain the 
reason for most of the isolates being able to consume this particular antibiotic though the 
concentration is still high. 
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Discussion 
 Surveying and collecting a small sample size of bacterial isolates from natural 
environments within Kentucky revealed a great diversity with at least ten genera containing 
known human pathogenic strains. The 27 genera discovered in this sample contained species 
resistant to colistin and tobramycin with a few resistant to carbenicillin, erythromycin, and 
irgasan. Though these bacterial isolates were collected from areas believed to have low human 
interactions, it can be noted that these resistant isolates are potentially able to transfer antibiotic 
resistance genes to non-resistant bacteria through means such as conjugation, transformation, and 
transduction.  It should also be noted that even though some of these strains are not common 
human pathogens, even “non-pathogenic” or commensal bacteria maybe able to cause infections 
in susceptible hosts.  As there are great number of people globally that are immunocompromised 
(e.g. HIV patients, patients undergoing chemotherapy, or patients who have recently had 
transplants and are chemically immunosuppressed) or have underlying conditions (e.g. severe 
diabetes, cystic fibrosis, severe burns) which tax the immune system, this work could reveal 
potential pathogens that may be difficult to eradicate.  The more that is learned about these 
strains in advance, the better off the treatment could potentially be for those afflicted by these 
bacteria. 
 The 36 representative isolates of the 27 genera showed variable responses to each 
antibiotic in the MIC assay. The antibiotics that resulted in a high MIC can be inferred as 
ineffective against the tested isolates. Other antibiotics with intermediate to low MIC can be seen 
as having some form of efficacy in combating these isolates. Colistin, penicillin, tobramycin, and 
trimethoprim have shown to be less effective in combating the bacterial isolates. 
Chloramphenicol, kanamycin, and nalidixic acid were effective against some bacterial strains, 
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but not others. This data and similar data from other groups will hopefully allow antibiotic usage 
to be re-evaluated and increase development of new antibiotics. Re-evaluating the use of 
antibiotics involves changing antibiotic dosage or the use of other treatment protocols such as 
homeopathic treatments. New antibiotics could be developed by slightly changing the chemical 
structure of the antibiotic, which could increase the efficacy, or identifying novel antibiotics 
from natural or synthetic sources. It should be noted that the MIC assay was done with only 
single antibiotics; testing with a combination of antibiotics could lead to synergistic effects of the 
antibiotics. 
 The bacterial isolates showed little capability of infecting the plant models. This could be 
due to the plant’s innate ability to fend off the bacterial invasion or a lack of virulence 
determinants specific for plants in the bacteria. Plants and bacteria have known symbiotic 
relationships, for example nitrogen-fixing bacteria that provide ammonia to plants and receive 
carbon compounds in return. When the interaction between the two is pathogenic (parasitic), 
plants have developed defense mechanisms against plant pathogenic bacteria through evolution. 
One unique mechanism that evolved in plants for protection was the production of specialized 
metabolites otherwise known as phytochemicals that convey antimicrobial properties [30]. In the 
detection of a bacterial invasion (inoculation sites), the plant may release the phytochemical to 
defend itself. On the other hand, the isolates may not be pathogenic against the two plant models 
and could be neutral or plant beneficial bacteria such as nitrogen-fixing bacteria. Either one of 
the two reasons (plant defenses or lack of plant virulence by bacteria) could explain why the 
majority of the plant samples were unaffected by the inoculation of the bacterial isolates; against 
known plant pathogens, the onion peels and lettuce leaves were effectively macerated. From the 
plant models, it could be seen that the yellow onion and lettuce may have antibacterial 
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phytochemicals to aid their defense against the bacterial invasions. These phytochemicals could 
be a source for antibiotic development [30]. 
 The fungal-bacterial interaction showed that the pathogenic fungus A. fumigatus was able 
to inhibit or outcompete approximately half of the isolates (most of which were Gram-positive 
bacteria) while C. albicans was able to inhibit a few of the isolates (most of which were Gram-
negative bacteria). A. fumigatus has been found to secrete antibacterial compounds which would 
explain the ability to inhibit half of the isolates [41]. C. albicans may also be able to inhibit the 
bacteria with antibacterial compounds. These compounds could be extracted and developed into 
antibiotics that are selective in terms of Gram stain (e.g. antibacterial compounds from A. 
fumigatus could be developed into antibiotics targeting Gram-positive bacteria). Certain fungi 
have been known to contain antibacterial compounds that have been extracted and developed 
into commonly used antibiotics such as penicillin from the fungus Penicillium [16].  
 Many isolates were unable to utilize most antibiotics as a sole carbon source, suggesting 
that resistance did not result in the catabolism of the antibiotic. Though most of the isolates were 
able to consume colistin, the concentration for colistin was much lower than the others (i.e. 0.10 
g/L instead of 0.50 g/L). Should this assay for colistin be repeated, colistin should be repeated 
with 0.50 g/L concentration. Out of the isolates that were able to utilize the antibiotics, the 
majority of them were isolated from soil environmental niches.  This is expected since the 
majority of antibiotic-producing microbes (e.g. Streptomyces species) are commonly found in 
soils; thus bacteria naturally found in soils will need to have resistance mechanisms but they do 
not have to include antibiotic consumption/breakdown in their defense arsenal. 
 When examining the most common genera found in this study, the most prevalent groups 
(i.e. Bacillus, Serratia, and Sphingobacterium) appeared to be highly resistant to the antibiotics 
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colistin, kanamycin, penicillin, and trimethoprim, and they were capable of utilizing the 
antibiotics as a sole carbon source. In regards to the fungal-bacterial interaction, both Bacillus 
and Serratia are inhibited by A. fumigatus while Sphingobacterium was able to outcompete the 
fungus. In the case of C. albicans, only Serratia was inhibited. From this, though Bacillus and 
Serratia are insensitive to almost half of the antibiotics used, the fungi were able to inhibit the 
bacteria through secretion of antibacterial compounds. Since the most prevalent genera are found 
in all four environments (i.e. association with animals or fungi, plants, water, and soils), 
resistance could be spread easily to other neighboring bacteria. These specific antibiotic resistant 
bacteria can be suppressed (with the exception of Sphingobacterium) by A. fumigatus’s 
antibacterial compound, which could make A. fumigatus a possible source of antibiotic 
development. 
 The main hypotheses of this project were that (i) these bacterial isolates would be 
resistant to a large collection of antibiotics, (ii) the bacterial isolates collected from soil 
environments would be able to consume some of the nine antibiotics as a carbon source, (iii) 
some bacterial isolates would be plant pathogens, and (iv) some bacterial isolates would be 
inhibited by antibacterial compounds produced by the fungi. From the assays, all hypotheses 
were strongly supported with the exception of one. The hypothesis that was not strongly 
supported was that some isolates were plant pathogens. Though some isolates showed plant 
tissue maceration, the data were not substantial enough to warrant the assignation of a plant 
pathogen (i.e. for most of them, either 0 or 1 replicate out of 3 showed mild tissue destruction). 
Though only a small sample number was collected, it can be generalized to the greater 
population of native bacteria within Kentucky to a certain extent. These bacteria are resistant to 
an abundant of common antibiotics and may be less susceptible to others. This continuous rise of 
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increased resistance could spread to other non-resistant bacteria. With the discovery of plant 
models and fungal interaction capable of inhibiting the bacteria collected, sources of antibiotics 
could be discovered from these assays. Native bacteria within Kentucky have shown increasing 
resistance towards common antibiotics. Though microbial interaction (e.g. conjugation or fungal-
bacterial interaction) may increase the spread of antibiotic resistance, reevaluation of antibiotic 
usage and development of new antibiotics from potential sources (e.g. plant models and fungi 
secretion) may allow the healthcare to be one step ahead in the arms race against bacteria. 
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I. Supplemental Figures 





















Supplementary Figure 3. Onion Infection Assay. Photos of the onion peels of a 
representative trial over a period of 2 days with photos taken in 24 hrs post infection. The 




Supplementary Figure 4. Lettuce Infection Assay. Photos of the lettuce cores over a period of 5 days 
with photos taken in 6 hrs and 12 hrs post infection. Controls are the farthest right column of lettuce 
cores with the top four cores (black circles) as the positive controls and the bottom three (red circles) as 




Supplementary Figure 4 continued. Lettuce Infection Assay. Photos of the lettuce cores over a 
period of 5 days with photos taken in 6 hrs and 12 hrs post infection. Controls are the farthest right 
column of lettuce cores with the top four cores (black circles) as the positive controls and the bottom 
three (red circles) as the negative controls. 
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Supplementary Figure 5. Fungal-Bacterial Interaction Assay. Plates of two isolates to show the streaking 
pattern.  In Panel A, the bacterial strain Arthrobacter nitroguajacolicus was streaked vertically followed by 
horizontal cross hatches of A. fumigatus (top three streaks) and C. albicans (bottom three streaks). In Panel B, A. 
fumigatus was struck vertically followed by streak of horizontal cross hatches of Chryseobacterium stagni; 
Chryseobacterium gambrini (top three streaks), Pseudomonas protegens (middle three streaks), and 
Paenibacillus apiarius (bottom three streaks). 
A. B. 
Bacterium growth unaffected by the fungus. 
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